Ieq Capital LLC Invests $447,000 in Rafael Holdings, Inc. $RFL

Key Points

• Ieq Capital LLC has acquired a new stake in Rafael Holdings, purchasing 238,878 shares valued at approximately $447,000, representing about 0.96% of the company.
• Rafael Holdings reported a loss of $0.19 per share for the last quarter, along with a revenue of $0.36 million and a negative net margin of 3,127.60%.
• Wall Street analyst ratings for Rafael were upgraded from a "sell" to a "hold" as of August 10th, reflecting a more positive outlook on the stock.

Ieq Capital LLC bought a new stake in Rafael Holdings, Inc. (NYSE:RFL - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 238,878 shares of the company's stock, valued at approximately $447,000. Ieq Capital LLC owned approximately 0.96% of Rafael as of its most recent filing with the Securities & Exchange Commission.

Separately, Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Rafael in the first quarter valued at about $26,000. 11.30% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Rafael from a "hold" rating to a "sell" rating in a research note on Friday.

Rafael Trading Up 1.6%

NYSE RFL traded up $0.02 during mid-day trading on Tuesday, reaching $1.36. 141,198 shares of the company's stock traded hands, compared to its average volume of 132,232. Rafael Holdings, Inc. has a 1-year low of $1.28 and a 1-year high of $3.19. The company has a fifty day simple moving average of $1.77 and a 200-day simple moving average of $1.73. The company has a market cap of $47.79 million, a price-to-earnings ratio of -1.45 and a beta of 0.89.

Rafael (NYSE:RFL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) earnings per share for the quarter. Rafael had a negative net margin of 3,127.60% and a negative return on equity of 24.75%. The business had revenue of $0.36 million for the quarter.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.